TXNIP and intermediate coronary syndrome: More specifically, TXNIP mRNA levels in leucocytes have also been investigated and are increased in patients with unstable angina pectoris [29] or with acute myocardial infarction [204], suggesting the role of TXNIP in atherosclerosis and the pathogenesis of cardiovascular diseases.